Opinion
By David Grant
Beating Big Pharma
WEDNESDAY, MAY 26, marked a watershed moment in California,
and maybe in the national drug-cost wars, but you might not have noticed.
For the first time, the state legislature voted for the complete "OURx
Bill of Rights" package of prescription drug reforms, putting Gov.
Arnold Schwarzenegger squarely on the spot to side either with citizens
or with the drug companies that are loading him up with donations.
Last January the OURx coalition, led by Senior Action Network, California
Alliance of Retired Americans, CALPIRG, Greenlining Institute, Consumers
Union, and the California Labor Federation, met in a small room in Sacramento.
The federal government had just failed, in the Medicare reform debacle,
to defend citizens from high drug prices. There had to be something
we could do in California, right now. From this emerged the OURx Bill
of Rights, to guarantee information on safety, effectiveness, and price
to every Californian, to end deceptive marketing practices that drive
up costs, and to pull back the cloak of secrecy on drug pricing.
Over the past five months our lobbyists have worked hard but
it was average citizens, most of them seniors, who put themselves on
the line and defeated the drug lobby. Despite more than half a million
dollars in contributions, phony press events with bogus front groups,
and all the suits at hand, the drug industry was, for the first time
ever, beaten back.
The OURx coalition motto is simple Big Pharma might buy votes
in Sacramento, but it can't buy voters in the community. Local groups
dug deep, spending thousands on chartering buses and organizing events
in San Francisco, Sacramento, and around the state. Amazed legislators
found respectful but determined groups of seniors an unaccustomed but
increasingly regular presence in their offices, invited or not. Legislators
in the districts were buttonholed at campaign events. All were forced
to take a stand, on the side of California or on the side of drug companies.
This isn't about buying drugs in Canada or saving a few dollars. Most
people don't want drugs from Canada; they want them from the corner
pharmacy just at Canadian prices. And because of high costs,
as many as one in five San Franciscans skip medications; for people
of color, it can be as high as 30 percent. Health and safety and lives
are at stake. Deadly diseases such as diabetes, high blood pressure,
and heart disease can only be controlled by drugs. Without medication,
people start dying.
Big Pharma defends the highest prices in the world on a few imaginary
grounds. Among them: (1) foreign drugs are unsafe, leaving aside
the fact that drugs such as Lipitor or Viagra are all foreign-made
and imported; and (2) science is expensive, leaving aside the fact that
Big Pharma spends about 11 percent of revenues on R&D, versus 34 percent
on marketing, advertising, and administration. It's not science but
TV commercials that cost so much.
Of course, the true reason is the bottom line. Does the United States
need the highest drug prices anywhere to develop not one or two but
three erectile dysfunction drugs? And should high prices break the backs
of low-income people, people of color, and seniors?
This week was just an opening round. The suits will be back with buckets
of greenbacks. But maybe they have feet of clay, starting to
crack. In March the San Francisco Board of Supervisors endorsed the
OURx package; in May the city launched an official Web site to
help buy drugs in Canada (www.sfdph.org/SFRx). And Senior Action Network
provides the first in the nation's generics-comparison Web site (www.drugcompare.org).
When people fight against powerful interests directly, in the halls
of Sacramento, it makes all the difference.
We invite you to take action for lower drug prices June 8 at the BIO
2004 conference at Fourth and Howard Streets at noon. And remind
all your state senators and assemblymembers and governor to vote for
the entire OURx Bill of Rights package.
David Grant is director of health policy for Senior Action Network.